On 26 May 2020 we hosted the Regional Selection of the EIT Health Catapult and 13 startups presented their MedTech, BioTech and Digital Health solutions during the online pitch competition. The expert jury examined the startups for their investment readiness and selected the six best DACH biotech, medtech and digital health startups for the EIT Health European Health Catapult semifinals. The selected startups feature an impressive range of innovative solutions, from VR-based cognitive training and high-quality prosthetics to phage-based therapy and protein expression platform.
The selected start-ups will receive intensive coaching on their value proposition and investor pitch, and then pitch and compete against the european-wide competition during the following semi-final events, taking place online on:
The finalists will compete in the European Health Catapult Final (1/2 December 2020).
These are the selected semi-finalists:
LenioBio – LenioBio is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell.
PhagoMed – PhagoMed Biopharma is a biotech company focused on the development of innovative, phage-based treatments against persistent bacterial infections and microbiome dysbiosis. PhagoMed has three active development programs in the fields of bacterial vaginosis, implant associated infections and urinary tract infections.
Amparo – Amparo’s vision is to empower 90% of the world’s 30 million amputees, giving them access to affordable, high-quality prosthetics. Amparo’s revolutionary prosthetic socket solution is the fastest, easiest and most affordable on the market.
Peragraft – Peragraft aims to develop and produce patient individualized implants for cardiovascular applications.
Digital Health Category:
LivingBrain – Living Brain uses their experience to focus their Virtual Reality based cognitive training, their medical software and their knowledge to help millions of people worldwide to achieve a more fulfilled and happier life for patients, decreased recovery time and support research companies gaining new insights in neuro-rehabilitation.
CardiLink – CardiLink enables remote monitoring of service-intensive, distributed medical devices.
EIT Health Germany wishes the best of luck to all six nominated companies in the semifinals!